Skip to content
Menu

Relay Therapeutics, Inc. RLAY

Full chart Compare
Set alert

Price alert · RLAY

All alert types
16.93 USD -0.34 (-2.00%)

As ofNov 17, 2026, 11:14 AM EST

16.75 Day range 17.42
6.25 52-week range 21.27
YTD
+100.06%
1 year
+155.66%

RLAY revenue history

Revenue is income from the company’s ordinary business activities.

15,355,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3115,355,0005,348,00053.44%
FY 20242024-12-3110,007,000-15,539,000-60.83%
FY 20232023-12-3125,546,00024,165,0001749.82%
FY 20222022-12-311,381,000-1,648,000-54.41%
FY 20212021-12-313,029,000-79,625,000-96.34%
FY 20202020-12-3182,654,00082,654,000Not meaningful
FY 20192019-12-3100Not meaningful
FY 20182018-12-310Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-08T14:24:18.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.